|
Recent
Blockbuster History
In
the period 1994-1998, the total pharmaceutical market grew
by 24%, but the top 20 products grew by 42%, according to
AstraZeneca CEO Dr Tom McKillop. Between 1998-2000, the
top 20 brands are estimated to grow by 75%, and the market
will be dominated by megabrands.
In
1998, according to Dr McKillop, 23 megabrands (using the
old definition of sales in excess of $1 billion) were on
the market, including Lipitor from Warner-Lambert/Pfizer,
Prozac from Eli Lilly and Norvasc from Pfizer. By 2002,
the number of potential megabrands has been estimated at
50, and these could represent 24% of the total pharmaceutical
market, according to Lehman Brothers.
The
following table shows the top ten products for 1998:
| Product |
Sales
in US$ billion |
|
|
| Losec |
4.444 |
| Zocor |
4.945 |
| Prozac |
2.588 |
| Norvasc |
2.331 |
| Lipitor |
1.926 |
| Renitec |
1.784 |
| Seroxat/Paxil |
1.687 |
| Zoloft |
1.668 |
| Augmentin |
1.547 |
| Claritin |
1.459 |
Source:
IMS HEALTH, MIDAS
02 Mar 2000, Copyright IMS HEALTH
|
